Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | Managing renal failure in patients with multiple myeloma

Efstathios Kastritis, MD, University of Athens, Athens, Greece, proposes treatment and management strategies for patients with multiple myeloma who exhibit renal failure, highlighting the value of incorporating anti-CD38 monoclonal antibodies (mAbs) when treating these patients.This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.